Hylasto S 8mg Injection
Prescription Required
Product introduction
Hylasto S 8mg Injection is a medicine used for treatment of pain due to osteoarthritis. This medicine is commonly given when when a patient does not respond to other conventional treatments. It reduces the friction in the joints and decreases the pain and swelling.
Hylasto S 8mg Injection is used to treat painful swelling and redness of the joints leading to severe pain
Hylasto S 8mg Injection is used to treat painful swelling and redness of the joints leading to severe pain
Uses of Hylasto S Injection
Benefits of Hylasto S Injection
In Treatment of Osteoarthritis
Osteoarthritis is a condition that causes pain and swelling in the joints of your hands, knees, hips and spine. Hylasto S 8mg Injection is most commonly used to treat knee pain caused by osteoarthritis. Hylasto S 8mg Injection helps restore the synovial fluid which helps in lubricating and cushioning the joint during movement. This way it restores the mobility and reduce the pain. Mild symptoms of osteoarthritis can sometimes be managed by doing light exercises, losing weight and suitable footwear.
Side effects of Hylasto S Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Hylasto S
- Injection site reactions (pain, swelling, redness)
- Muscle pain
- Joint pain
How to use Hylasto S Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Hylasto S Injection works
Hylasto S 8mg Injection is the salt form of hyaluronic acid. It helps supplement the viscous properties of the fluid in knee joint thereby reducing friction in the joints and helps them work smoothly.
Safety advice
Alcohol
SAFE
Consuming alcohol with Hylasto S 8mg Injection does not cause any harmful side effects.
Pregnancy
CONSULT YOUR DOCTOR
Information regarding the use of Hylasto S 8mg Injection during pregnancy is not available. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of Hylasto S 8mg Injection during breastfeeding is not available. Please consult your doctor.
Driving
SAFE
Hylasto S 8mg Injection does not usually affect your ability to drive.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Hylasto S 8mg Injection in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Hylasto S 8mg Injection in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Hylasto S 8mg Injection
₹17600.0/Injection
Viscolan One 8mg Injection
Denzai Innovations & Therapeutics Pvt Ltd
₹14800/injection
16% cheaper
Fact Box
Chemical Class
Nonsulfated Glycosaminoglycan
Habit Forming
No
Therapeutic Class
PAIN ANALGESICS
Action Class
Osteoarthritis- Hyaluronic acid
Patient concerns
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Buys LM, Elliott ME. Osteoarthritis. In: DiPiro JT, Talbert RL, Yee GC, et al., editors. Pharmacotherapy: A Pathophysiologic Approach. 9th ed. New York, New York: McGraw-Hill Education; 2014. [Accessed 24 Jan. 2019] (online) Available from:
- Sodium hyaluronate [Patient Information Leaflet]. [Accessed 27 Nov. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). Sodium hyaluronate. [Accessed 02 Apr. 2019] (online) Available from:
- Sodium hyaluronate [Package Insert]. Doylestown, Pennsylvania: OrthogenRx, Inc. [Accessed 06 Aug. 2023]. (online) Available from:
Marketer details
Name: Zydus Cadila
Address: Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹17600
Inclusive of all taxes
1.0 Injection in 1 prefilled syringe
SOLD OUT
Notify me